Skip Ribbon Commands
Skip to main content
Menu
Dr Aaron Tong

Dr Tong Kian Ti Aaron

MBBS (Singapore), MRCP (UK), MMed (Int Med) (Singapore), FAMS (Nuclear Medicine)

Senior Consultant

Singapore General Hospital

Specialty: Nuclear Medicine and Molecular Imaging

Conditions Treated by this Doctor:
General Nuclear Medicine, PET/CT.

Clinical Appointments

  • Senior Consultant Nuclear Medicine and Molecular Imaging Singapore General HospitalSingapore General Hospital
  • Clinical Governance Officer (Nuclear Medicine)
  • Visiting Consultant Department of Radiology Sengkang General HospitalSengkang General Hospital

Academic Appointments

  • Adjunct Assistant Professor, Duke-NUS Medical School
  • Clinical Lecturer, NUS Yong Loo Lin School of Medicine

Profile

Dr Aaron Tong graduated from the National University of Singapore in 2005. He completed his AST and senior residency in Nuclear Medicine and PET (Singapore).

Dr Tong is currently the Chairman of the Chapter of Nuclear Medicine in the College of Radiologists, Academy of Medicine, Singapore.

Dr Tong has keen interest and takes an active role in various research and educational activities. He has published multiple papers in peer review journals and also written several book chapters.

Education

  • Fellow of the Academy of Medicine, Singapore 2015
  • Master of Medicine (Internal Medicine), National University of Singapore 2011
  • Member of the Royal College of Physicians (UK), 2010
  • Bachelor of Medicine and Bachelor of Surgery, National University of Singapore 2005

Professional Appointments and Committee Memberships

  • Chairman, Chapter of Nuclear Medicine, College of Radiologists, Academy of Medicine Singapore 2021 - present
  • Member, Nuclear Medicine Society Singapore

Awards

 

  • SingHealth Duke-NUS RadSci ACP Education Award - Outstanding Faculty (2018)
  • British Journal of Radiology - Best of BJR (2017)
  • Singapore General Hospital IQC - Silver Award (2016)
  • SingHealth Residency - Outstanding Resident Award (2014)
  • Radiological Society of North America - RSNA Travel Award for Young Investigators in Molecular Imaging (2013)

Research Interests

Publications

  1. Loke KSH, Tham WY, Bharadwaj P, Keng FYJ, Huang Z, Idu M, Wong YM, Tan PKS, Zaheer S, Khor YM, Ng DCE, Wong WY, Tong AK. Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT). J Nucl Cardiol. 27:1005-1009 (2020)
  2. Tong AK, Tham WY, Too CW, Tai DW, Chow PK, Ng DC. Molecular Imaging and Therapy of Liver Tumors. Seminars in Nuclear Medicine. 2020 Sept;50(5):419-433
  3. Tham WY, Tong AKT, Loke KSH, Chio L, Lim GKY, Seah XY, Ng DCE, Yan SXX, Lam WWC. Divide and Conquer: Strategies in Singapore to manage a Nuclear Medicine Department During COVID-19. Journal of Nuclear Medicine Technology June 2020;48(2): 98-101
  4. Tay WL, Chng CL, Tien CS, Loke KS, Lam WW, Fook-Chong SM, Tong AK. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease. Ann Acad Med Singapore. 2019 Jun;48(6):181-187
  5. Huang HL, Tong AKT, Thang SP, Yan SX, Lam WWC, Loke KSH, Tang CYL, Cheng LTJ, Ooi GSK, Low HC, Magsombol BM, Tham WY, Goh CXY, Tan CJ, Khor YM, Zaheer S, Bharadwaj P, Xie W, Ng DCE. Current status and Growth of Nuclear Theranostics in Singapore. Nucl Med Mol Imaging. 2019 Apr:53(2):96-101
  6. Tay WL, Tong AKT, Hui KYD, Tang YLC, Chng CL. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort. Hell J Nucl Med. 2017 Sep-Dec;20(3):227-231
  7. Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK. Yttrium-90 hepatic radioembolization: Clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016 Jun; 89 (1062) : 20150943.
  8. Tong AK, Zhang ZX, Zaheer S, Yan XS. Dual phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan. Clin Imag. 2016 May-Jun;40(3):486-491.
  9. Rodríguez LS, Thang SP, Li H, Khor LK, Tay YS, Myint KO, Tong AK. A descriptive analysis of remnant activity during 90Y resin microspheres radioembolization of hepatic tumours: technical and dosimetric implications. Ann Nucl Med. 2016 Apr;30(3):255-261
  10. Khor LK, Loi HY, Sinha AK, Tong KT, Goh BC, Loh KS, Lu SJ.  68Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma. Head Neck. 2016 Apr;38(4):E76-80
  11. Tong AK, Neo HS, Kok TY. Disseminated lymphoma evolving into Neurolymphomatosis during Mid-cycle of chemotherapy detected by 18F FDG PET/CT. Ann Acad Med Singapore. 2015 Nov;44(11):545-7
  12. Khor LK, Loi HY, Sinha AK, Tong KT, Goh BC, Loh KS, Lu SJ. Correlation between 68Ga-DOTA-NOC PET/CT and 18F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2015 June;42(7):1162-3.
  13. Thang SP, Tong AK, Ng DC. Postmastectomy / Axillary node dissection chyloma: The additional value of SPECT/CT lymphoscintigraphy. J Breast Cancer. 2014 Sep;17(3):291-4.
  14. Tong AK, Tan SY, Go YY, Lam WW. Cardiac structural abnormalities associated with IgG4-related coronary periarteritis and inflammation revealed by multimodality imaging. Can J Cardiol. 2014 Aug;30(8):956.e15-7.
  15. Tong AK, Mann KP, Schuster DM, Yan X. A rare presentation of myocardial plasmacytoma assessed by FDG PET/CT. Clin Nucl Med. 2014 Jul;39(7):643-5.
  16. Thang SP, Tong AK, Lam WW, Ng DC. SPECT/CT in Musculoskeletal Infections. Semin Musculoskelet Radiol. 2014 Apr;18(2):194-202.

Research Trials

Clinical Trials

  1. Site-PI: “18F-MISO PET guided dose escalation in nasopharyngeal carcinoma – a feasibility and planning study” sponsored by Terry Fox Foundation, 2016 ($69,000).
  2. Principal Investigator: “Functional imaging with Gallium-68 DOTAPEPTDE PET/CT and 131I-metaiodobenzylguanidine (MIBG) in order to determine feasibility of  Peptide Receptor Radionuclide Therapy and MIBG therapy (combined therapy)  in neuroblastoma” by SingHealth Foundation, Singapore. Clinical Research Start-up Grant category 2015 ($24,000).